Part I of this series opened with a recent study on schizophrenia that has sparked renewed controversy on the legitimacy of pre-screening for and treating psychological afflictions, most of which (in the generic sense) can be defined as "thought disorders." It focused on the University of North Carolina's Schizophrenia Research Center under Dr. John H. Gilmore, whose team claimed to have located an anomaly in the MRIs of "at-risk," male babies: larger brains and larger lateral ventricles.
On July 15 the U.S. Army reported 32 confirmed or suspected suicides among its troops in June, the highest number in a single month since the Vietnam conflict. Of the deaths, 21 were active duty soldiers, while 11 were reserve soldiers on inactive status. Seven of the soldiers killed themselves during combat in Iraq or Afghanistan, and the Army reported that among the 32 killed, ten had been deployed multiple times.
So much for President Obama’s executive order banning federal funding of abortions under ObamaCare. Two states, Pennsylvania and Maryland, have now accepted federal funds for high-risk insurance pools, and both offer significant abortion coverage.
Every First Lady, it seems, has to have a cause. Lady Bird Johnson had her beautification program. Nancy Reagan had “Just Say No” to drugs. Michelle Obama’s cause of choice (or perhaps of focus groups) is childhood obesity.
Pharmaceutical manufacturer SmithKline Beecham, now GlaxoSmithKline, found in a 1999 study that its diabetes medicine, Avandia, posed serious heart attack risks — then buried the study for the next 11 years, according to the New York Times, which recently obtained documents related to the study and the cover-up.